Riskpilot← Back to searchSign inGet full accessNORDIC LABORATORIES ApS
APSActiveCVR 26672953Nygade 6, 3.Hospital activities · NACE 8610Est. 200222 employees
Revenue 2025
DKK 11,6M
-3% vs 2024
EBITDA margin
31.4%
-19% vs 2024
Equity ratio
32.8%
Financial strength
Net profit 2025
DKK 2,8M
-35% vs 2024
| Revenue | DKK 11,6M | -3% |
| EBITDA | DKK 3,6M | -19% |
| Net profit | DKK 2,8M | -35% |
| Total assets | DKK 12,4M | +4% |
| Equity | DKK 4,1M | -29% |
| Employees | 22 | — |
Legal name
NORDIC LABORATORIES ApS
CVR number
26672953
Legal form
Anpartsselskab
NACE code
8610 · Hospital activities
Founded
1. juli 2002
Share capital
DKK 125.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er markedsføring af laboratorie analyser
Address
Nygade 6, 3.
Phone
+4533751000
Email
cm@nordic-labs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 955 | 1.353 | 2.378 | 2.360 | 2.262 | 3.706 | 4.291 | 6.730 | 7.643 | 8.993 | 7.326 | 6.814 | 11.943 | 11.579 |
| Staff expenses | -846 | -1.076 | -1.976 | -2.108 | -1.903 | -2.532 | -3.398 | -4.146 | -4.598 | -5.865 | -6.890 | -6.703 | -7.453 | -7.939 |
| EBITDA | 109 | 277 | 402 | 251 | 359 | 1.174 | 893 | 2.584 | 3.045 | 3.128 | 436 | 111 | 4.490 | 3.640 |
| Depreciation & amort. | 17 | 33 | 65 | 143 | 142 | -113 | -94 | -400 | -697 | -742 | -394 | -29 | -0 | -0 |
| EBIT | 92 | 245 | 337 | 108 | 217 | 1.061 | 799 | 2.184 | 2.348 | 2.387 | 42 | 82 | 4.490 | 3.640 |
| Net financials | -1 | 1 | 5 | 5 | -0 | -3 | -84 | -64 | -164 | 497 | -790 | 564 | 860 | -8 |
| Profit before tax | 90 | 245 | 342 | 113 | 217 | 1.058 | 715 | 2.120 | 2.184 | 2.884 | -747 | 646 | 5.351 | 3.632 |
| Tax | 30 | 65 | 94 | 36 | 51 | 248 | 175 | 478 | 491 | 640 | 15 | 52 | 1.031 | 805 |
| Net profit | 60 | 180 | 248 | 77 | 166 | 810 | 540 | 1.642 | 1.693 | 2.243 | -762 | 594 | 4.320 | 2.827 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 861 | 1.404 | 1.579 | 2.053 | 1.652 | 2.608 | 3.258 | 4.981 | 7.889 | 11.164 | 5.378 | 6.918 | 11.889 | 12.422 |
| Equity | 185 | 306 | 504 | 481 | 572 | 1.382 | 1.599 | 2.966 | 4.159 | 4.902 | 1.240 | 1.834 | 5.754 | 4.080 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 523 | 545 | 728 | 0 | 0 | 1.083 | 631 |
| Short-term debt | 664 | 1.091 | 1.031 | 1.483 | 1.024 | 1.172 | 1.572 | 1.450 | 3.186 | 5.534 | 4.139 | 5.084 | 5.053 | 7.711 |
| Total debt | 664 | 1.091 | 1.031 | 1.483 | 1.024 | 1.172 | 1.572 | 1.973 | 3.731 | 6.262 | 4.139 | 5.084 | 6.135 | 8.342 |
EBITDA margin
31.4%
This company
15.8%
Market median
+99% vs market
20122025
Equity ratio
32.8%
This company
38.2%
Market median
+14% vs market
20122025
Return on equity
69.3%
This company
18.4%
Market median
+277% vs market
20122025
Net profit margin
24.4%
This company
8.1%
Market median
+201% vs market
20122025
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20122025
Debt / equity
2.04×
This company
0.62×
Market median
-229% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Executive Officer | Chief Executive Officer | 2002 | — | — |
CJ Management | Management | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2002 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NORDIC GROUP ApS | Company | 100.0% | 100.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORDIC GROUP ApS
NORDIC LABORATORIES ApS Board members of NORDIC LABORATORIES ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annemette Heller | Chief Executive Officer | 0 companies |
| Christopher John Liebe Moore | Management | 0 companies |
| Kim Madsen | Chairman | 0 companies |